Drug application
BENDAMUSTINE HYDROCHLORIDE (BENDAMUSTINE HYDROCHLORIDE)
Drugs@FDA ANDA 204104 · PHARMOBEDIENT
Key facts
| Drug name | BENDAMUSTINE HYDROCHLORIDE |
|---|---|
| Active ingredients | BENDAMUSTINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 204104 |
| Company | PHARMOBEDIENT |
| Dosage forms | POWDER, INTRAVENOUS |
| Strength | 25MG/VIAL |
| Marketing status | Discontinued |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Apr 28, 2023 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.